Island Pharmaceuticals Limited (ASX:ILA)
Australia flag Australia · Delayed Price · Currency is AUD
0.3450
+0.0050 (1.47%)
Oct 16, 2026, 4:10 PM AEST

Island Pharmaceuticals Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
1021123310812
Market Cap Growth
8.79%240.21%238.62%26.43%-34.48%-48.02%
Enterprise Value
8910629946
Last Close Price
0.340.380.140.080.090.13

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-1.84----
PS Ratio
361.40397.83277.977.74--
PB Ratio
7.598.364.626.434.322.73
P/TBV Ratio
8.038.844.626.434.322.73

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
-373.52244.397.37--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
---0.28--
Net Debt / Equity Ratio
-0.96-0.96-1.01-0.81-1.12-1.11
Net Debt / EBITDA Ratio
1.261.26----
Asset Turnover
0.030.030.020.55--
Quick Ratio
24.4324.4322.092.447.648.28
Current Ratio
24.6224.6222.272.457.778.44
Return on Equity (ROE)
-95.50%-95.50%-90.37%-173.37%-92.75%-48.65%
Return on Assets (ROA)
-60.11%-60.11%-49.16%-77.59%-52.32%-30.44%
Return on Capital Employed (ROCE)
-76.80%-76.80%-55.30%-188.50%-162.90%-65.10%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-9.64%-8.75%-11.86%-29.34%-36.66%-22.12%
Buyback Yield / Dilution
-55.94%-55.94%-91.98%-11.11%-0.42%-334.32%